Measles virus vaccine live attenuated
- Generic Name
- Measles virus vaccine live attenuated
- Brand Names
- M-M-R II, Proquad
- Drug Type
- Biotech
- Unique Ingredient Identifier
- MFZ8I7277D
Overview
Measles virus vaccine live attenuated is a live virus vaccine for simultaneous vaccination against measles, which is a common childhood disease. The vaccine is prepared from the attenuated line of measles virus, derived from Enders' attenuated Edmonston strain and propagated in chick embryo cell culture.
Background
Measles virus vaccine live attenuated is a live virus vaccine for simultaneous vaccination against measles, which is a common childhood disease. The vaccine is prepared from the attenuated line of measles virus, derived from Enders' attenuated Edmonston strain and propagated in chick embryo cell culture.
Indication
Measles virus vaccine is used to prevent measles in combination with other virus vaccines, such as the rubella and Mumps virus vaccine.
Associated Conditions
- Measles
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|---|---|---|---|---|
ORAL | 30 [hp_X] in 1 mL | 2025/05/15 | 83027-0071 | ||
ORAL | 12 [hp_X] in 1 mL | 2025/05/06 | 43742-2266 | ||
ORAL | 16 [hp_X] in 1 mL | 2025/05/21 | 83027-0050 | ||
ORAL | 12 [hp_X] in 1 mL | 2025/05/27 | 43742-2145 | ||
The Wellness Center for Research and Education, Inc. | ORAL | 12 [hp_X] in 1 mL | 2025/05/28 | 50181-0042 |
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|---|---|---|---|---|---|---|---|
EMEA/H/C/000604 | the netherlands | N/A | Authorised | 2006/05/05 | 2006/02/23 | 34 |
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|---|---|---|---|---|
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | ≥ 10³ CCID50/dose | 2009/04/03 | SIN13627P | ||
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | ≥ 10³ CCID50/dose | 2009/04/03 | SIN13627P | ||
INJECTION, POWDER, FOR SOLUTION | min 1000 TCID50 | 1999/03/22 | SIN10822P | ||
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 3.00 log TCID 50/ dose | 2008/10/23 | SIN13563P | ||
INJECTION, POWDER, FOR SOLUTION | min 1000 CCID50/0.5 ml | 1988/06/24 | SIN02056P | ||
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1.0 x10⁸ - 5.0 x10⁸ PFU/ml | 2009/12/28 | SIN13748P |
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|
No NMPA products found
No NMPA products found for this drug
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|---|---|---|---|---|
HK-54831 | merck sharp & dohme (asia) ltd | Part 1, Schedule 1 & Schedule 3 Poison & Antibiotic | POM | 2006/10/05 |
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|---|---|---|---|---|
97842 | Active | 2003/11/03 | Measles virus | ||
107286 | Active | 2005/11/16 | Measles virus | ||
201877 | Active | 2012/12/12 | Measles virus | ||
118449 | Active | 2006/02/14 | Measles virus | ||
337388 | Active | 2020/08/12 | Measles virus | ||
118451 | Active | 2006/02/14 | Measles virus | ||
126153 | Active | 2007/02/08 | Measles virus | ||
126157 | Active | 2007/02/08 | Measles virus |